When Mario Guzman, the creator of cannabis genetics Gelato and Sunset Sherbert, travels to Europe for events, he looks forward to meeting up with longtime friends and exchanging seeds.

"All of our global friends come, and we share genetics and talk about what we're all planting for the following year," Guzman told MJBizDaily during a recent phone call.

He likens the experience to the seed market that has existed for decades in the coffee shops of Amsterdam.

"They were really the culture of it: the passionate backbone of all seed sales in Europe," Guzman said of Amsterdam-based growers and seed breeders, adding that until the medical marijuana market got a toehold in the United States, legacy growers brought seeds from outside the U.S. that later became the bedrock of today's regulated market. Read story >

A former top California marijuana official is claiming in a lawsuit filed last week that she was fired after superiors brushed off concerns about widespread problems, including fraud, at state-licensed cannabis testing labs.

Tanisha Bogans, the former deputy director of laboratory services at the California Department of Cannabis Control, alleges she was fired after sharing reports of rampant THC potency inflation and labs' deliberate failures to detect pesticides and mold, according to a lawsuit filed Monday in Los Angeles Superior Court.

Bloomberg Law first reported Bogans' lawsuit, which claims unlawful retaliation and violations of whistleblower protections as well as unpaid business expenses. Read story >

Breeding Technology for the Next Evolution of Cannabis Genetics

Cannabis breeding is entering a new era, driven by cutting-edge technologies that are revolutionizing how we understand and develop genetics. This session will explore the latest advancements in breeding technology, including CRISPR gene editing, marker-assisted selection and advanced phenotyping. Attendees will learn how these innovations are unlocking new possibilities for creating cannabis strains with targeted cannabinoid profiles, disease resistance and improved environmental adaptability.

The reMind Psychedelics Business Forum is where the most important conversations surrounding psychedelics take place.

This year's event welcomes Dr. Sue Sisley, MD a Montana/Arizona-based physician practicing Internal Medicine & Psychiatry and serves as Principal Investigator of Scottsdale Research Institute.

Dr. Sisley (and her research associate, Dodger the dog) specialize in FDA-approved randomized controlled trials to examine the safety and efficacy of DEA-licensed lab-farmed psilocybin mushrooms and cannabis flower.

Join us at our Keynote Presentation to learn how real patients manage conditions such as chronic pain, opioid reduction, PTSD, depression and anxiety using alternative medicine.

Mark your calendars and secure your spot at the reMind Psychedelics Business Forum today! Learn More >